Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHill’s Opaganib Compared to Matched Case-Control Group

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice